INS and type 1 diabetes mellitus: We showed that orally administered gluconate, by itself, has no effect on the fasting or post-prandial glucose levels of type-1 diabetic (T1D) mice, and confirmed that introduction of the components encoding gluconate-switched insulin production restored normoglycemia in T1D mice fed with gluconate.